To collect the efficacy and safety information in subjects who have been treated with Zyvox (linezolid) for vancomycin resistance Enterococcus faecium infection for their appropriate use in daily practice.
Study Type
OBSERVATIONAL
Enrollment
41
Patients should be treated with Zyvox (linezolid) 600 mg every twelve hours.
Number of Participants With Adverse Drug Reactions.
All observed or volunteered adverse events and the investigator's opinion of the causal relationship to the study treatment were reported as adverse events. Definition of adverse drug reaction was treatment related adverse events which were evaluated in company with the causal relationship to the investigational product.
Time frame: Baseline to 8 weeks
Number of Participants Categorized as Responders (Cure and Improved) to Zyvox (Linezolid) Treatment.
Clinical overall effectiveness was evaluated by investigators based on clinical symptoms, laboratory test and investigator judgement, at the end of observation period. Clinical rating (cure/improved/not cured/unable to evaluate) was carried out. Definition of cured was disappearance of clinical symptom and/or Laboratory test abnormality. Definition of improved was improvement in clinical symptoms and/or laboratory test abnormality.
Time frame: Baseline to 8 weeks
Adverse Drug Reactions Unlisted in Japanese Package Insert.
The adverse drug reactions that have not been included in Japanese package insert.
Time frame: Baseline to 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.